Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial


Mohammad Ali, David Sack and colleagues re-analyze data from a cluster randomized controlled trial of oral cholera vaccine to determine the potential effectiveness of a ring vaccination strategy.


Vyšlo v časopise: Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial. PLoS Med 13(9): e32767. doi:10.1371/journal.pmed.1002120
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002120

Souhrn

Mohammad Ali, David Sack and colleagues re-analyze data from a cluster randomized controlled trial of oral cholera vaccine to determine the potential effectiveness of a ring vaccination strategy.


Zdroje

1. Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e0003832. doi: 10.1371/journal.pntd.0003832 26043000

2. Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med. 2014;370:2111–2120. doi: 10.1056/NEJMoa1312680 24869721

3. Ivers LC, Farmer PE, Pape WJ. Oral cholera vaccine and integrated cholera control in Haiti. Lancet. 2012;379:2026–2028. doi: 10.1016/S0140-6736(12)60832-0 22656874

4. Lucas ME, Deen JL, von Seidlein L, Wang XY, Ampuero J, Puri M, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med. 2005;352:757–767. doi: 10.1056/NEJMoa043323 15728808

5. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013;13:1050–1056. doi: 10.1016/S1473-3099(13)70273-1 24140390

6. Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. Controlling endemic cholera with oral vaccines. PLoS Med. 2007;4:e336. doi: 10.1371/journal.pmed.0040336 18044983

7. Martin S, Costa A, Perea W. Stockpiling oral cholera vaccine. Bull World Health Organ. 2012;90:714. doi: 10.2471/BLT.12.112433 23109735

8. You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, et al. Risk map of cholera infection for vaccine deployment: the eastern Kolkata case. PLoS ONE. 2013;8:e71173. doi: 10.1371/journal.pone.0071173 23936491

9. Luquero FJ, Banga CN, Remartinez D, Palma PP, Baron E, Grais RF. Cholera epidemic in Guinea-Bissau (2008): the importance of “place”. PLoS ONE. 2011;6:e19005. doi: 10.1371/journal.pone.0019005 21572530

10. Osei FB, Duker AA. Spatial and demographic patterns of cholera in Ashanti region—Ghana. Int J Health Geogr. 2008;7:44. doi: 10.1186/1476-072X-7-44 18700026

11. Strassburg MA. The global eradication of smallpox. Am J Infect Control. 1982;10:53–59. 7044193

12. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857–866. doi: 10.1016/S0140-6736(15)61117-5 26248676

13. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27–38.

14. Shapiro ED. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. Pediatr Infect Dis J. 2004;23:127–131. doi: 10.1097/01.inf.0000109248.32907.1d 14872178

15. Deb BC, Sircar BK, Sengupta PG, De SP, Sen D, Saha MR, et al. Intra-familial transmission of Vibrio cholerae biotype E1 Tor in Calcutta slums. Indian J Med Res. 1982;76:814–819. 7169236

16. Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, et al. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2014;91:738–742. doi: 10.4269/ajtmh.14-0095 25114012

17. Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, Khanam F, et al. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2012;19:690–698. doi: 10.1128/CVI.05615-11 22441386

18. Rahman A, Rashu R, Bhuiyan TR, Chowdhury F, Khan AI, Islam K, et al. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol. 2013;20:1592–1598. doi: 10.1128/CVI.00347-13 23945156

19. Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study. PLoS Med. 2015;12:e1001867. doi: 10.1371/journal.pmed.1001867 26305226

20. Qadri F, Wierzba TF, Ali M, Chowdhury F, Khan AI, Saha A, et al. Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh. N Engl J Med. 2016;374:1723–1732. doi: 10.1056/NEJMoa1510330 27144848

21. Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011;29:8285–8292. doi: 10.1016/j.vaccine.2011.08.108 21907255

22. Wierzba TF, Kar SK, Mogasale VV, Kerketta AS, You YA, Baral P, et al. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India. Vaccine. 2015;33:2463–2469. doi: 10.1016/j.vaccine.2015.03.073 25850019

23. George CM, Monira S, Sack DA, Rashid MU, Saif-Ur-Rahman KM, Mahmud T, et al. Randomized controlled trial of hospital-based hygiene and water treatment intervention (CHoBI7) to reduce cholera. Emerg Infect Dis. 2016;22:233–241. doi: 10.3201/eid2202.151175 26811968

24. Troeger C, Sack DA, Chao DL. Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg. 2014;91:1181–1189. doi: 10.4269/ajtmh.14-0159 25294614

25. Dowdy DW, Golub JE, Chaisson RE, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proc Natl Acad Sci U S A. 2012;109:9557–9562. doi: 10.1073/pnas.1203517109 22645356

26. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, et al. Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med. 2012;9:e1001165. doi: 10.1371/journal.pmed.1001165 22303287

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2016 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Získaná hemofilie - Povědomí o nemoci a její diagnostika

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa